We harness stem cell biology and nuclear reprogramming techniques to convert skin fibroblasts into medically-relevant cell types for the clinic. In addition, we are interested in understanding how cell fate decisions are made during embryonic development and what are the elements that regulate cell plasticity in “terminally” differentiated cells.
HHMI International Research Scholar
EMBO young investigator
Krill Prize for “Excellence in Scientific Research”, Wolf Foundation
KY Cha Award in “Stem Cell Technology”, American Society for Reproductive Medicine
“Stem Cells and Regenerative Medicine” Award, Boyalife company, Science magazine and Science translational medicine magazine